FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

Revance Therapeutics, Inc.: operating_income

One fact, its scope and the complete path back to the official record.

Period: 2022-01-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/9c6be2ef-3c84-4b88-9cc3-453783e24f2c

Reported value

$-341.958M{"amount": -341958000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"}
Entity
Revance Therapeutics, Inc.
Metric
operating_income
Period
2022-01-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001479290-23-000028 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:41:26.423200+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001479290/operating-income/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies